Taylor E. Branyan
Research Subjects
Research Interests
Taylor E. Branyan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Farida Sohrabji
Department of Neuroscience and Experimental Therapeutics, Women's Health in Neuroscience Program, College of Medicine, Texas A&M University-Health Science Center, Bryan, TX, USA
4 shared publications - Dayalan Sampath
Texas A&M University, College Station, TX USA
1 shared publication - Karyn M. Frick
Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, WI, United States
1 shared publication Kylee Grace Markowsky
Texas A&M University Health, Brayan, TX USA
1 shared publication- Lisa R. Taxier
Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
1 shared publication - Miriam Pillerová
University of Wisconsin-Milwaukee, Department of Psychology, Milwaukee, WI, USA; Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic
1 shared publication
Latest Publications
- Open Access
- 23 August 2024
- Published by Elsevier in Hormones and Behavior
- Vol. 165, 105618
Astrocytic glutamate transport is essential for the memory-enhancing effects of 17β-estradiol in ovariectomized mice
- 23 August 2024
- Published by Elsevier in Hormones and Behavior
- Vol. 165, 105618
Open AccessAstrocytic glutamate transport is essential for the memory-enhancing effects of 17β-estradiol in ovariectomized mice
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S1)
Sex differences in stroke‐induced cognitive impairment and the impact of Mir20a‐3p treatment in middle‐aged Sprague Dawley rats
Background: Stroke is a leading risk factor for dementia. Our previous studies show that the small non‐coding RNA, mir20a‐3p, is neuroprotective for stroke and reduces sensory‐motor impairment in the acute phase (Branyan et al., 2021). In this study, we used a battery of tests to assess the integrated functioning of affective and cognitive circuits after stroke in males and females, as well as the impact of mir20a‐3pMethod: Middle‐aged (acyclic) females and males were subject to ischemic stroke using endothelin‐1 in the left middle cerebral artery (MCA) region. Mir20a‐3p mimics or scrambled oligo was administered i.v. 4h and 24h after stroke with a supplementary dose at 60d. Long‐term cognitive changes were assessed by contextual fear conditioning (CFC) and the novel object recognition test (NORT).Result: Both males and females showed significant sensory‐motor impairment due to stroke in the acute phase, which was attenuated by Mir20a‐3p treatment. In the chronic phase, cognitive function was assessed by cued and contextual fear conditioning, evaluated by percent freezing during acquisition, retrieval, and extinction of fear memory. When measured 30, 60 and 100d after stroke, retrieval of fear memory was significantly reduced over time in sham and stroke males and females. However, linear regression analysis revealed that among females, the rate of decline of fear memory was significantly accelerated in the stroke group that received scrambled oligo treatment, while the rate of decline in the Mir20a‐3p group was similar to the sham group, indicating a protective effect of this drug. Surprisingly, stroke+ scrambled treated male rats did not show an accelerated decline. We further examined declarative memory (as assessed by the Novel Object Recognition Task) and noted that there was a decline over time in both males and females.Conclusion: This study shows that cognitive impairment is selectively affected by stroke and that despite the fact that acute sensory‐motor impairment is seen to a similar extent in males and females, stroke significantly affected the retrieval of fear memory in females but not males. Moreover, treatment with Mir20a‐3p abrogated this effect of stroke.
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S1)
Sex differences in stroke‐induced cognitive impairment and the impact of Mir20a‐3p treatment in middle‐aged Sprague Dawley rats
Background: Stroke is a leading risk factor for dementia. Our previous studies show that the small non‐coding RNA, mir20a‐3p, is neuroprotective for stroke and reduces sensory‐motor impairment in the acute phase (Branyan et al., 2021). In this study, we used a battery of tests to assess the integrated functioning of affective and cognitive circuits after stroke in males and females, as well as the impact of mir20a‐3pMethod: Middle‐aged (acyclic) females and males were subject to ischemic stroke using endothelin‐1 in the left middle cerebral artery (MCA) region. Mir20a‐3p mimics or scrambled oligo was administered i.v. 4h and 24h after stroke with a supplementary dose at 60d. Long‐term cognitive changes were assessed by contextual fear conditioning (CFC) and the novel object recognition test (NORT).Result: Both males and females showed significant sensory‐motor impairment due to stroke in the acute phase, which was attenuated by Mir20a‐3p treatment. In the chronic phase, cognitive function was assessed by cued and contextual fear conditioning, evaluated by percent freezing during acquisition, retrieval, and extinction of fear memory. When measured 30, 60 and 100d after stroke, retrieval of fear memory was significantly reduced over time in sham and stroke males and females. However, linear regression analysis revealed that among females, the rate of decline of fear memory was significantly accelerated in the stroke group that received scrambled oligo treatment, while the rate of decline in the Mir20a‐3p group was similar to the sham group, indicating a protective effect of this drug. Surprisingly, stroke+ scrambled treated male rats did not show an accelerated decline. We further examined declarative memory (as assessed by the Novel Object Recognition Task) and noted that there was a decline over time in both males and females.Conclusion: This study shows that cognitive impairment is selectively affected by stroke and that despite the fact that acute sensory‐motor impairment is seen to a similar extent in males and females, stroke significantly affected the retrieval of fear memory in females but not males. Moreover, treatment with Mir20a‐3p abrogated this effect of stroke.
- 1 April 2023
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (4) , E165-E166
April Stroke Literature Synopses (Preclinical)
- 1 April 2023
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (4) , E165-E166
April Stroke Literature Synopses (Preclinical)
- 23 May 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (6) , E232-E233
June Literature Synopsis
- 23 May 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (6) , E232-E233
June Literature Synopsis